M.HaradaH
Global GLP-1 Analogues Market Size & Trends Report Segmented by Product (Ozempic, Mounjaro, Wegovy, Rybelsus, Saxenda), Route of Administration (Subcutaneous, Oral), Application (Diabetes, Obesity), End-user Analysis & Regional Forecast to 2031 The global GLP-1 analogues market size is expected to grow at a CAGR of 14% during the forecast period
its about how we feel when we look in the mirror
Improvement rates were 70.2%, 71.4%, and 77.6%, for urinary, gait, and cognitive domains, respectively
Cholesterol & Blood Pressure Improvement Studies show that GLP-1 medications lower LDL (bad) cholesterol and triglycerides while promoting healthy levels of HDL (good) cholesterol
Although stroke was not a primary outcome in RCT that assessed the effect of GPL1RA in high-risk patients, subgroup analyses of several CVOTs suggest that these medications may reduce the risk of cerebrovascular injury